# Spinifex Pharmaceuticals

Startup profile on Capital Atlas: https://capitalatlas.ai/startups/spinifex-pharmaceuticals

- Industry: Biotechnology
- Headquarters: Melbourne, Australia
- Website: www.spinifexpharma.com.au
- Total disclosed funding: $59M
- Latest round: Series C (Apr 10, 2014)
- Investors on record: 6

## About

Established in 2005 and based in Australia, Spinifex Pharmaceuticals is a  biotechnology company that engages in development of products for the treatment of chronic pain.

## Funding rounds

- Series C, Apr 10, 2014, $45M — Canaan Partners, GBS Venture Partners, Uniseed, Novo Holdings, Brandon Capital Partners, UniQuest Limited
- Series B, Aug 23, 2011, $6.4M — GBS Venture Partners, Uniseed, Brandon Capital Partners, UniQuest Limited
- Series B, Sep 4, 2008, $4.7M — GBS Venture Partners, Uniseed, Brandon Capital Partners
- Series A, Jul 26, 2005, $3.3M — GBS Venture Partners, Uniseed, UniQuest Limited

## Investors

- GBS Venture Partners (https://capitalatlas.ai/funds/gbs-venture-partners) — Series A, Series B, Series C
- Uniseed (https://capitalatlas.ai/funds/uniseed) — Series A, Series B, Series C
- UniQuest Limited — Series A, Series B, Series C
- Brandon Capital Partners (https://capitalatlas.ai/funds/brandon-capital-partners) — Series B, Series C
- Canaan Partners (https://capitalatlas.ai/funds/canaan-partners) — Series C
- Novo Holdings — Series C